This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Infex Therapeutics Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: James Kirkham: Innovator in Antibacterial Compounds
Introduction
James Kirkham is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating bacterial infections. His innovative work focuses on enhancing the efficacy of antibacterial agents.
Latest Patents
James Kirkham holds a patent for the "Synthesis of pyrrole acid derivatives." This invention pertains to the synthesis of compounds that can be utilized in conjunction with other antibacterial agents, specifically a class known as carbapenems. The compounds produced through his novel methods serve as enzyme inhibitors, particularly targeting metallo-β-lactamase enzymes.
Career Highlights
Kirkham is associated with Infex Therapeutics Limited, where he applies his expertise in developing new antibacterial therapies. His work is crucial in the ongoing battle against antibiotic resistance, a growing concern in modern medicine.
Collaborations
James collaborates with esteemed colleagues, including Andrew Wilkinson and Ian Cooper. Their combined efforts contribute to advancing research in antibacterial treatments.
Conclusion
James Kirkham's innovative work in synthesizing antibacterial compounds positions him as a key figure in the fight against bacterial infections. His contributions are vital for the development of effective treatments in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile